Literature DB >> 1091976

Recent observations on central nervous system lupus erythematosus.

D A Bennahum, R P Messner.   

Abstract

The recent literature on CNS-SLE has been reviewed. An improved prognosis is noted that is thought to be due to the use of high-dose corticosteroids. The frequencies of the various neurologic and psychiatric findings are discussed, and a distinction is noted between organic psychoses and functional psychiatric complaints. The question of corticosteroids versus cerebral vasculitis as the cause of the neuropsychiatric symptomatology in SLE is examined, and the necessity of clear psychiatric diagnosis and treatment is stressed. Recent observations on HL-A antigens, complement, immunoglobulins, virus, and immunocomplexes suggest that the latter are prominent in CNS-SLE, but that an infectious agent may be etiologic in the genesis of SLE. Fifty-four patients not previously reported are discussed. Thirty-eight of them had neuropsychiatric manifestations. The treatment of CNS-SLE with cytotoxic agents, in addition to corticosteroids, is considered, and the experience of the authors with such treatment is presented.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1091976     DOI: 10.1016/0049-0172(75)90012-8

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  11 in total

1.  Neuropsychiatric lupus erythematosus, cerebral infarctions, and anticardiolipin antibodies.

Authors:  R A Fields; W L Sibbitt; H Toubbeh; A D Bankhurst
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

2.  The neuro-ophthalmology of systemic lupus erythematosus.

Authors:  S Lessell
Journal:  Doc Ophthalmol       Date:  1979-09-17       Impact factor: 2.379

3.  A naturally occurring antibody in New Zealand mice cytotoxic to dissociated cerebellar cells.

Authors:  R J Harbeck; A A Hoffman; S A Hoffman; D W Shucard; R I Carr
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

Review 4.  Current concepts of neuropsychiatric systemic lupus erythematosus (NP-SLE).

Authors:  R A Asherson; S D Denburg; J A Denburg; R M Carbotte; N Futrell
Journal:  Postgrad Med J       Date:  1993-08       Impact factor: 2.401

5.  Transverse myelitis with systemic lupus erythematosus.

Authors:  I Scharf; M Nahir; J Hemli
Journal:  J Neurol       Date:  1977-06-13       Impact factor: 4.849

6.  Correlation between anti-DNA antibody titre and psychiatric manifestations in systemic lupus erythematosus.

Authors:  Y Levo; J Kalaci; A I Pick; M Golomb
Journal:  Postgrad Med J       Date:  1976-12       Impact factor: 2.401

7.  Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus.

Authors:  W L Sibbitt; R R Sibbitt; R H Griffey; C Eckel; A D Bankhurst
Journal:  Ann Rheum Dis       Date:  1989-12       Impact factor: 19.103

8.  The pathogenesis of neuropsychiatric lupus.

Authors:  J A Denburg; P Temesvari
Journal:  Can Med Assoc J       Date:  1983-02-01       Impact factor: 8.262

9.  Myelopathy in neonatal and infantile lupus erythematosus.

Authors:  E M Kaye; I J Butler; S Conley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-07       Impact factor: 10.154

10.  Recurrent transverse myelitis associated with collagen disease.

Authors:  M Yamamoto
Journal:  J Neurol       Date:  1986-06       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.